Based on our recent observation that BRAF is a client protein of TRAP1 [12], an HSP90 molecular chaperone upregulated in several human cancers including CRC [13–16], we evaluated the molecular mechanisms responsible for resistance to apoptosis induced by BRAF activation in human CRCs. This evidence concerns the gene BRAF and colorectal carcinoma.